Featured Speaker: James R. Heath, PhD, Professor and President of Institute of Systems Biology, Seattle, and Sean Mackay, CEO and Co-Founder, IsoPlexis
Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.
In this Webinar we discuss:
Learn about the technological innovations that can help you dramatically accelerate your immunotherapies and drug development.
Explore several case studies showing how IsoPlexis highly multiplexed bulk & single-cell capabilities enabled researchers to capture complexities connected to in vivo biology.
